Detecting Gastrointestinal Manifestations in Patients With Systemic Sclerosis Using Anti-gAChR Antibodies

Arthritis Research & Therapy
doi 10.1186/s13075-020-2128-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Should We Look for Anti-Rna Polymerase III Antibodies in Systemic Sclerosis Patients With Anti-Centromere or Anti-Topoisomerase I Antibodies?

European Journal of Internal Medicine
Internal Medicine
2017English

P610 Gastrointestinal Manifestations in Systemic Lupus Erythematous

2019English

Molecular Subtypes of Systemic Sclerosis in Association With Anti-Centromere Antibodies and Digital Ulcers

Genes and Immunity
ImmunologyGenetics
2009English

Abnormalities of T Lymphocyte Subsets in Systemic Sclerosis Demonstrated With Anti-Cd45ra and Anti-Cd29 Monoclonal Antibodies.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1991English

Increased Intrathecal High-Avidity Anti-Tau Antibodies in Patients With Multiple Sclerosis

PLoS ONE
Multidisciplinary
2011English

Maxillofacial Manifestations of Systemic Sclerosis: Case Report

Akdeniz Medical Journal
2018English

Gut Microbiota Profile in Systemic Sclerosis Patients With and Without Clinical Evidence of Gastrointestinal Involvement

Scientific Reports
Multidisciplinary
2017English

Evaluation and Management of Esophageal Manifestations in Systemic Sclerosis

Annals of Gastroenterology
2018English

The Articular Manifestations of Progressive Systemic Sclerosis (Scleroderma).

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1982English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy